Hospital Albert Einstein
Kenneth Gollob is an accomplished expert in immuno-oncology and translational research, currently serving as the Director of the Center for Research in Immuno-oncology at Hospital Albert Einstein. Gollob also holds the position of Editor-in-Chief for the journal Einstein and has a significant background in life-saving diagnostics as the founder of BRISA Biotech. Previous roles include leadership positions at A.C.Camargo Cancer Center and Instituto Mario Penna, along with editorial responsibilities at Springer Nature. Gollob's research focuses on multiomics approaches for cancer therapeutics and biomarker discovery, complemented by extensive academic experience in immunology at various institutions, including Stanford University and the Universidade Federal de Minas Gerais. Gollob earned a PhD in Microbiology and Immunology from the University of Colorado School of Medicine and a B.S. in Molecular, Cellular and Developmental Biology from the University of Colorado Boulder.
This person is not in the org chart
This person is not in any teams
Hospital Albert Einstein
10 followers
Hospital Israelita Albert Einstein was opened in 1971. From then on, it became a reference in treatments with cutting-edge technology, humanized and expanded its borders with social responsibility actions and teaching and research activities. Today, the Sociedade Beneficente Israelita Brasileira Albert Einstein is at the forefront of important projects, that show how the public-private partnership can bear fruit for the community. Housed at the Instituto Israelita de Ensino e Pesquisa Albert Einstein, education and research activities are the engine of innovation that are not restricted to patients at Hospital Israelita Albert Einstein and encompass technical, undergraduate and graduate courses, sophisticated training and research. clinical and experimental. Einstein is now a health system.